5 Oncology Stocks Wall Street Predicts Will Rally 135% or More
The oncology industry is expected to grow considerably in 2022, driven by the rising occurrence of cancer in the U.S. population. Furthermore, increasing investments by biopharmaceutical companies and the government should fuel the industry's growth. Given the industry's bright growth prospects, Wall Street analysts expect the stocks of quality oncology…
StockNews.com ·
Benzinga
StockNews.com
